To elucidate theroles of CB2R in neuroinflammatory and neurodegenerative diseases,the coadministration of RNB-61 and the P-gp inhibitortariquidar could be performed, mitigating the ambiguities arisingfrom CB1R activity46 (Table 5). Here, CNR1 is linked to neurodegenerative disease.